ArticleNeurocritical care2026
Neurogenic Cerebral Edema: Proposed Mechanism for Vasogenic Cerebral Edema.
Article in Neurocritical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Global cerebral edema (GCE) is a frequent and devastating manifestation of early brain injury after aneurysmal subarachnoid hemorrhage (aSAH), yet its exact inciting biology and sequence of events remain incompletely explained. In this viewpoint, we propose neurogenic cerebral edema (NCE) as a mechanistic hypothesis for vasogenic edema after aSAH, in which autonomic disequilibrium may amplify blood-brain barrier permeability within otherwise mixed cellular, ionic, and vasogenic edema. We integrate evidence that aSAH perturbs the central autonomic network, producing a sympathetic catecholamine surge that can coexist with parasympathetic system activation. This autonomic disequilibrium may indirectly amplify established neurovascular-unit injury pathways, including sulfonylurea receptor 1 (SUR1)-transient receptor potential melastatin 4 (TRPM4) upregulation and tight-junction dysfunction, thereby increasing the vasogenic component of early cerebral edema. We further highlight a pathophysiological parallel with neurogenic pulmonary edema, wherein neurally mediated hemodynamic and permeability forces culminate in protein-rich extravasation across an endothelial barrier. An analogous process in the brain provides a coherent framework for blood-brain barrier (BBB) breakdown and diffuse edema after aSAH. To illustrate the imaging pattern motivating prospective testing, we present a patient with poor-grade aSAH with malignant edema and diffusely elevated apparent diffusion coefficient values. Because autonomic measurements and direct BBB permeability assessment were not obtained, this case illustrates a vasogenic component but does not establish a neurogenic etiology. Our premise is that both arms of autonomic control must be considered. This hypothesis also emphasizes the need for prospective validation using BBB permeability imaging and translational autonomic biomarkers.
Indexed as
Identifiers
42881358What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.